1. MAPK/ERK Pathway Apoptosis
  2. JNK Apoptosis
  3. JNK-IN-14 TFA

JNK-IN-14 TFA is a potent and selective JNK inhibitor with IC50 values of 1.81, 12.7 and 10.5 nM for JNK1, JNK2 and JNK3, respectively. JNK-IN-14 TFA induces early-stage apoptosis and G2/M cell cycle arrest. JNK-IN-14 TFA can be used for cancer research

For research use only. We do not sell to patients.

JNK-IN-14 TFA

JNK-IN-14 TFA Chemical Structure

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Other In-stock Forms of JNK-IN-14 TFA:

Other Forms of JNK-IN-14 TFA:

Top Publications Citing Use of Products

View All JNK Isoform Specific Products:

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

JNK-IN-14 TFA is a potent and selective JNK inhibitor with IC50 values of 1.81, 12.7 and 10.5 nM for JNK1, JNK2 and JNK3, respectively. JNK-IN-14 TFA induces early-stage apoptosis and G2/M cell cycle arrest. JNK-IN-14 TFA can be used for cancer research[1]

In Vitro

JNK-IN-14 (compound 11e) (2.5 μM-5 μM, 24 h) TFA leads to slight early-stage apoptosis in a concentration-dependent manner in K562 cells[1].
JNK-IN-14 (1.25-5 μM, 24 h) TFA induces G2/M cell cycle arrest in K562 cells[1].
JNK-IN-14 TFA exhibits a GI50 of 1.28 μM against NCI K562 cells[1].
JNK-IN-14 (2.5 μM-5 μM, 24 h) TFA inhibits beclin-1 production in K562 leukemia cells[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Cycle Analysis[1]

Cell Line: K562 Human Leukemia Cell
Concentration: 1.25 μM, 2.5 μM, 5 μM
Incubation Time: 24 h
Result: Showed viable cells arrest at the G2/M phase with values of 45.33% at 1.25 μM, 2.5 μM at 62.99%, and 5 μM at 98.97%.

Apoptosis Analysis[1]

Cell Line: K562 Human Leukemia Cell
Concentration: 2.5 μM, 5 μM
Incubation Time: 24 h
Result: Resulted in early-stage apoptosis with 1.94%, and 2.14% for 2.5 and 5 μM, respectively.

Western Blot Analysis[1]

Cell Line: K562 Human Leukemia Cell
Concentration: 2.5 μM, 5 μM
Incubation Time: 24 h
Result: Inhibited beclin-1 production at higher concentrations in K562 leukemia cells.
Molecular Weight

635.65

Formula

C29H32F3N5O6S

Appearance

Solid

SMILES

O=C(O)C(F)(F)F.CC(C)(N1C=C(C(C2=CC(O)=CC=C2)=N1)C3=CC=NC(NCCCNS(=O)(C4=CC=C(C=C4)O)=O)=C3)C

Shipping

Room temperature in continental US; may vary elsewhere.

Storage
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
JNK-IN-14 TFA
Cat. No.:
HY-156182A
Quantity:
MCE Japan Authorized Agent: